Expression of CBFB-MYH11, the human leukemia inv(16) fusion protein results in apoptosis and altered gene expression
A recent review of peptide and related drug approvals described a field expanding through new techniques that make the molecules more stable and easier to deliver
eLife 9 , e49178 (2020)

Ingredients: Water, Dipropylene Glycol, Glycerin, Niacinamide, Methylpropanediol, Glyceryl Glucoside, Galactomyces Ferment Filtrate, Glycereth-26, Erythritol, Polyglyceryl-10 Laurate, Hydroxyacetophenone, Panthenol, Caprylyl Glycol, Hydrolyzed Jojoba Esters, Ethylhexylglycerin, Adenosine, Carbomer, Glucose, Xanthan Gum, Arginine, 1,2-Hexanediol, Butylene Glycol, Citric Acid, Polyquaternium-51, Citrus Aurantium Bergamia Fruit Oil, Diethylhexyl Sodium Sulfosuccinate, Pantolactone, Sodium Citrate, Lavandula Angustifolia Oil, Glutathione, Sodium Hyaluronate, Oryza Sativa Extract, Ascorbic Acid, Pyrus Malus Fruit Extract, Dipotassium Glycyrrhizate, Hydrogenated Lecithin, Gluconolactone, Brassica Oleracea Italica Extract, Prunus Serrulata Flower Extract, Nelumbo Nucifera Germ Extract, Lilium Tigrinum Extract, Copper Tripeptide-1, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Sodium Hyaluronate Crosspolymer, Hydroxypropyltrimonium Hyaluronate, Potassium Hyaluronate, Hydrolyzed Sodium Hyaluronate, Pentylene Glycol, Sodium Acetylated Hyaluronate, Disodium EDTA, Limonene, Linalool
